IRVINE, Calif., April 17, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has negotiated a deal to begin seeding the 100 Acres in Minden County Nevada adding to the 250 acres of farm lands in the San Joaquin Valley, California for its Industrial Commercial Hemp Grow Initiatives.
Tag Archives: CBIS
CBIS and RCDU Sign Another Large California Cultivation Land Deal for Two Hundred and Fifty Acres, Scheduled to be Seeded all at Once for Maximum Harvest and Research Production
IRVINE, Calif., April 13, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has negotiated a deal with the Members of the Winnemucca Tribe Shoshoni MBS Fee Lands for 250 acres of HRM farm lands in the San Joaquin Valley, California.
CBIS Ramps Up Production and Releases More New Products to Meet the Substantial Requests From Self-Medicating Patients Across the Country as it Highlights Moonlight Cannabis as its Newest Spotlight Dispensary for the Month of April 2017
IRVINE, Calif., March 27, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that it has substantially increased its production for its self-medicating patient product line distributed through cannabis dispensaries in California.
Cannabis Science Senior Executives to Co-Chair Special Session and Deliver a Keynote Speech at the Global Health Catalyst Summit at Harvard Medical School
IRVINE, Calif., March 1, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that its President, CEO and Co-Founder, Raymond C. Dabney, will be a keynote speaker and panelist at the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017.
Crown Baus Capital Corp. Acquires 100-Acre Investment Participation in Cannabis Science’s California and Nevada Property and Drug Development Projects
BEVERLY HILLS, Calif., Feb. 17, 2017 /Weed Wire/ — Crown Baus Capital Corp. (OTC PINK: CBCA) announces the Company acquires 100-acre investment participation in the Cannabis Science, Inc. (OTC PINK: CBIS) Property and Drug Development Projects spread across California and Nevada.
Cannabis Science Stock Chart Technical Analysis
Cannabis Science Inc (OTC:CBIS) — Stock Chart Technical Analysis for Jan. 23, 2017.
Cannabis Science Orders Multiple Greenhouse Structures for its 2nd Pilot 33,000 Sq. Ft. Drug Development Facility Buildout in Douglas County, Nevada
IRVINE, Calif., Dec. 21, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medications, has started work on its second 33,000 sq. ft. pilot cannabinoid drug development and manufacturing facility in Douglas County, Nevada.
Cannabis Science Signs a 320-Acre Allotment Property Development Deal in Humboldt County, Nevada with Members of the Winnemucca Tribal Allotments Led by Chief Bill
IRVINE, Calif., Oct. 26, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) announced it has just signed a new agreement that will provide an additional 320 acres of allotment development land in Humboldt County, Nevada.
Cannabis Science Activates Its Critical Financial Security Department to Specialize in the Worldwide Industry Deficiency in Risk Mitigation, Banking, Payment Processing, and Cash and Asset Movement
IRVINE, Calif., Sept. 2, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce the development and opening of the Cannabis Science Financial Security Department.
Cannabis Science and the Research Foundation Begins Protocols for California Legal Patients to Receive the New CBIS MDI Rescue Inhaler for Its First Observational Study Intending to Lead Into Clinical Trials
IRVINE, Calif., Aug. 12, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is happy to announce the intent to seek out 20 - 25 potential candidates suffering from Asthma/COPD and other critical ailments.
Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables
IRVINE, Calif., Aug. 11, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis based medicines, is happy to announce their first batch order for the previously announced cannabinoid based inhalation medicine for Asthma/COPD has been placed.
Twenty Acre Indoor/Outdoor Cultivation Facility in Northern California in the Final Stages of Escrow Awaiting Transfer of Ownership to Cannabis Science, Inc.
IRVINE, Calif., Aug. 1, 2016/Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced they are in the final stages of escrow to transfer the 20-acre Northern California cultivation property into its name and commence indoor/outdoor cultivation and production on the land.
Cannabis Science Develops Inhalation Medication for Those Suffering Asthma/COPD via Nebulizer, Targets National Markets
IRVINE, Calif., July 29, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce they will release an inhalation medication for those suffering asthma/COPD for use in patient nebulizers.
Cannabis Science 2016 Growth Guidance; Project Briefs, Cash-Flow Projections, and Current Historic Cannabis Industry Advancements; Industry Growth Indicators
IRVINE, Calif., July 20, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to provide its future operations and growth guidance based on its current projects, cash-flow projections, and current historic market advancements.
Cannabis Science Guidance; Corporate Headquarters Relocated to California as it Negotiates for a Los Angeles, California Laboratory/Medical Treatment Center
LOS ANGELES, June 30, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced the relocation of their corporate headquarters to Irvine, California.
Cannabis Science’s Mieko Hester-Perez Confirms CBIS Premiere Sponsorship Role at “We Cann Mix,” a Diverse Cannabis Community and Business Mixer Event in Los Angeles, CA
LOS ANGELES, June 23, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced their sponsorship of the “We Cann Mix” event, which is a mixer event intended for patients, advocates, entrepreneurs, scientists, and other enthusiastic members of the cannabis community.
Cannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles; Coined, “Cannabis Kills Cancer,” a Celebratory Fund Raiser
LOS ANGELES, June 16, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, partners with FHP.TV & Kush Boys Studios to host its “black tie, red carpet” event in Los Angeles.
Positive Cannabinoid Testing Data in California Prompts Cannabis Science Lab Expansions for IGXBio’s GenePro FDA Investigational New Drug (IND) Number 015982 for Further Drug Development to Identify & Develop Agonist Cannabinoids for GenePro
LOS ANGELES, March 18, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) announces that it is expanding its California clinical drug development operations to work with its partner IGXBio, Inc. in developing effective therapeutics using IGXBio’s Immuonotherapy (GenePro®, also referred to as Δ4SHIVKU2) FDA Investigational New Drug (IND). Number 015982.
Cannabis Science, Inc. (CBIS) Continues to Support CNN’s Dr. Sanjay Gupta for His Ongoing Efforts to Educate the Public on the Effectiveness of Medical Cannabis for Patients in Need
LOS ANGELES, Feb. 29, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) continues to support top surgeon and CNN Medical Correspondent Dr. Sanjay Gupta for his historic and high profile work educating the U.S. and the world about the benefits of medical cannabis and support for the medical cannabis community.
Cannabis Science Targets Successful Autism Treatments and Brings Family Autism Advocate Mieko Hester-Perez on Its Scientific Advisory Board
COLORADO SPRINGS, Colo., Feb. 8, 2016/ Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced its next critical ailment target is autism and brings Mieko Hester-Perez on its Scientific Advisory Board to lead this charge.
CBIS & Purple Haze Properties Launch “Jimi’s Meds” eCommerce Website Powered by Cannabis Science and Showcased This Weekend at the High Times Cannabis Cup in Southern California
COLORADO SPRINGS, Colo., Jan. 28, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) is pleased to announce additional cannabinoid medicinal product releases, this time through its Purple Haze Properties partners focused on a brand new line called “Jimi’s Meds.”
Cannabidiol “CBD” Strain of Medical Marijuana Establishing New CBD-Oil Nutraceutical Marketplace - Company Aims for Sales of CBD Products in all 50 States
Medical Marijuana and Cannabidiol (CBD Oils) gains momentum towards acceptance as viable medical treatment, significant clinical trial underway for possible seizure treatment and other CBD treatable ailments: Earth Science Tech, Inc. (OTC: ETST), GW Pharmaceuticals plc. (NASDAQ: GWPH), Cannabis Science, Inc. (OTC: CBIS), Easton Pharmaceuticals Inc. (OTC: EAPH) and Hemp, Inc. (OTC: HEMP)
Small Business Operations to Large Scale Companies Take Steps to Increase Security Surveillance - Company Selected for Comprehensive Cannabis Security System Installation
Security and Surveillance needs become top priority in Cannabis / Legal Marijuana industry as sector continues expansion and growth for the following emerging companies: DirectView Holdings, Inc. (OTC: DIRV), Nuvilex, Inc. (OTC: NVLX), GW Pharmaceuticals plc (NASDAQ: GWPH), Singlepoint, Inc. (OTC: SING) and Cannabis Science, Inc. (CBIS).